D-0337-2018 Class I Terminated

Recalled by AuroMedics Pharma LLC — East Windsor, NJ

FDA drug recall D-0337-2018 was initiated by AuroMedics Pharma LLC on Dec 20, 2017 and is designated Class I. Reason for recall: Presence of Particulate Matter; white particulate matter identified as mold was found in one bag The recall status is terminated (terminated Jun 24, 2019). Affected quantity: 9,050 bags.

Recall details

Product Type
Drugs
Report Date
Feb 14, 2018
Initiation Date
Dec 20, 2017
Termination Date
Jun 24, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,050 bags

Product description

Linezolid Injection 600 mg/300 mL (2 mg/mL), 300 mL Single-use, ready-to-use flexible plastic infusion bags in a foil laminate overwrap, Rx only, Mfd in India for: AuroMedics Pharma LLC, Dayton, NJ --- NDC 55150-242-51

Reason for recall

Presence of Particulate Matter; white particulate matter identified as mold was found in one bag

Distribution pattern

Product was distributed throughout United States.

Code information

Lot # CLZ160007, Exp August 2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0337-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0337-2018. Report a data issue: hello@regdatalab.com.